| Identifiers | |
|---|---|
|
|
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| ECHA InfoCard | 100.161.971 |
| Chemical and physical data | |
| Formula | C7H9NO6 |
| Molar mass | 203.149 g/mol |
| 3D model (Jmol) | |
|
|
|
|
|
|
|
DCG-IV is a research drug which acts as a group-selective agonist for the group II metabotropic glutamate receptors (mGluR2/3). It has potent neuroprotective and anticonvulsant effects in animal studies, as well as showing anti-Parkinsonian effects, but also impairs the formation of memories.